Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma.

J Clin Med · 2022 · PMC8836712 · PMID 35160279

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Data on OS did not reach statistical significance [ 26 ].

also in 111,027 other papers

a strong trendno p-value reported

Research on melanoma has shown how PFS and OS showed either a strong trend or significantly better outcomes as TMB (tumour mutational burden) increased when treated with immunotherapy [ 25 ]. 6.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.